Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Oligonucleotide Synthesis Market: By Product Type, By Nucleic Acid Type By Applications, By End User and Geography
Oligonucleotide synthesis market size was valued at US$ 9.2 billion in 2023 and is poised to grow at a CAGR of 16.6% from 2024-2030. Oligonucleotide synthesis is the chemical process of creating short, single-stranded sequences of nucleic acids (DNA or RNA) called oligonucleotides. These sequences are essential in various life science research, diagnostics, and therapeutic applications. Oligonucleotide Synthesis is synthesis of short fragments of the nucleic acids which have a defined chemical structure.
This process of chemical synthesis enables provide a rapid access to the custom-made oligonucleotides. The building blocks are coupled sequentially which further helps in growing the customized oligonucleotide chain. The research report on Oligonucleotide Synthesis Market contains the COVID-19 in light of changes in consumer behaviour and demand, purchasing patterns, supply chain re-routing, market dynamics, and government involvement. The revised report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.
Study Period
2024-2030Base Year
2023CAGR
16.60%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The increase in adoption of advanced technologies are expected to increase the growth of the market. The surge in initial investments in research and development, companies focused on novel technologies are anticipated to fuel the growth of the market. Furthermore, these R&D activities are adding scope for the advent of new products which is likely to enhance the growth of the market, providing opportunities to the manufactures.
The increasing government support in developing technologies such as the oligonucleotide synthesis technology and the genomic technologies is enriching the growth of the market. Personalized medicine is playing a vital role, expected to add fuel for the growth of the market. However, the stringent government regulations in approval of oligonucleotide-based therapeutics are expected to hamper the growth of the market.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 9.2 billion |
Market CAGR |
16.60% |
By Product Type |
|
By Application |
|
By End-User |
|
Download Free Sample Report
The oligonucleotide synthesis market size was valued at US$ 9.2 billion in 2023
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The oligonucleotide synthesis market key players are Integrated DNA Technologies, Inc., GenScript, Eurofins Scientific SE, Bioneer Corporation, Kaneka Corporation (Eurogentec), Biolegio B.V., Eton Bioscience, Inc.
1. Executive Summary |
2. Global Oligonucleotide Synthesis Market Introduction |
2.1. Global Oligonucleotide Synthesis Market - Taxonomy |
2.2. Global Oligonucleotide Synthesis Market -Definitions |
2.2.1. Product Type |
2.2.2. Nucleic Acid Type |
2.2.3. Application |
2.2.4. End User |
2.2.5. Region |
3. Global Oligonucleotide Synthesis Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Current Trends |
3.5. Global Oligonucleotide Synthesis Market Dynamic Factors - Impact Analysis |
3.6. Mergers, Acquisitions, and Collaborations |
4. Global Oligonucleotide Synthesis Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Oligonucleotide Synthesis Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1. Reagents |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Equipment |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Services |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Oligonucleotide Synthesis Market, By Nucleic Acid Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1. DNA |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. RNA |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Oligonucleotide Synthesis Market, By Application, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1. Therapeutic Applications |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Research Applications |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Diagnostic Applications |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global Oligonucleotide Synthesis Market, By End User, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1. Hospitals |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Pharmaceutical & Biotechnology Companies |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Diagnostic Laboratories |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. CROs and CMOs |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Academic Research Institutes |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. Global Oligonucleotide Synthesis Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. MEA |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global Oligonucleotide Synthesis Market - Opportunity Analysis Index, By Product Type, Nucleic Acid Type, Application, and End User, and Country, 2024 - 2030 |
10. North America Oligonucleotide Synthesis Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Reagents |
10.1.2. Equipment |
10.1.3. Services |
10.2. Nucleic Acid Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. DNA |
10.2.2. RNA |
10.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Therapeutic Applications |
10.3.2. Research Applications |
10.3.3. Diagnostic Applications |
10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.4.1. Hospitals |
10.4.2. Pharmaceutical & Biotechnology Companies |
10.4.3. Diagnostic Laboratories |
10.4.4. CROs and CMOs |
10.4.5. Academic Research Institutes |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.5.1. United States |
10.5.2. Canada |
10.6. North America Oligonucleotide Synthesis Market - Opportunity Analysis Index, By Product Type, Nucleic Acid Type, Application, and End User, 2016-2027 |
10.7. North America Oligonucleotide Synthesis Market Dynamics - Trends |
11. Europe Oligonucleotide Synthesis Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
11.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Reagents |
11.1.2. Equipment |
11.1.3. Services |
11.2. Nucleic Acid Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. DNA |
11.2.2. RNA |
11.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Therapeutic Applications |
11.3.2. Research Applications |
11.3.3. Diagnostic Applications |
11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.4.1. Hospitals |
11.4.2. Pharmaceutical & Biotechnology Companies |
11.4.3. Diagnostic Laboratories |
11.4.4. CROs and CMOs |
11.4.5. Academic Research Institutes |
11.5. Country Level Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.5.1. UK |
11.5.2. Germany |
11.5.3. France |
11.5.4. Italy |
11.5.5. Spain |
11.5.6. Rest of Europe |
11.6. Europe Oligonucleotide Synthesis Market - Opportunity Analysis Index, By Product Type, Nucleic Acid Type, Application, and End User, 2016-2027 |
11.7. Europe Oligonucleotide Synthesis Market Dynamics - Trends |
12. Asia Pacific Oligonucleotide Synthesis Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
12.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Reagents |
12.1.2. Equipment |
12.1.3. Services |
12.2. Nucleic Acid Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. DNA |
12.2.2. RNA |
12.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.3.1. Therapeutic Applications |
12.3.2. Research Applications |
12.3.3. Diagnostic Applications |
12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.4.1. Hospitals |
12.4.2. Pharmaceutical & Biotechnology Companies |
12.4.3. Diagnostic Laboratories |
12.4.4. CROs and CMOs |
12.4.5. Academic Research Institutes |
12.5. Country Level Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.5.1. China |
12.5.2. India |
12.5.3. ANZ |
12.5.4. Japan |
12.5.5. Rest of APAC |
12.6. Asia Pacific Oligonucleotide Synthesis Market - Opportunity Analysis Index, By Product Type, Nucleic Acid Type, Application, and End User, 2016-2027 |
12.7. Asia Pacific Oligonucleotide Synthesis Market Dynamics - Trends |
13. MEA Oligonucleotide Synthesis Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
13.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Reagents |
13.1.2. Equipment |
13.1.3. Services |
13.2. Nucleic Acid Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. DNA |
13.2.2. RNA |
13.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.3.1. Therapeutic Applications |
13.3.2. Research Applications |
13.3.3. Diagnostic Applications |
13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.4.1. Hospitals |
13.4.2. Pharmaceutical & Biotechnology Companies |
13.4.3. Diagnostic Laboratories |
13.4.4. CROs and CMOs |
13.4.5. Academic Research Institutes |
13.5. Country Level Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.5.1. GCC Countries |
13.5.2. South Africa |
13.5.3. Rest of MEA |
13.6. MEA Oligonucleotide Synthesis Market - Opportunity Analysis Index, By Product Type, Nucleic Acid Type, Application, and End User, 2016-2027 |
13.7. MEA Oligonucleotide Synthesis Market Dynamics - Trends |
14. Latin America Oligonucleotide Synthesis Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
14.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Reagents |
14.1.2. Equipment |
14.1.3. Services |
14.2. Nucleic Acid Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.2.1. DNA |
14.2.2. RNA |
14.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.3.1. Therapeutic Applications |
14.3.2. Research Applications |
14.3.3. Diagnostic Applications |
14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.4.1. Hospitals |
14.4.2. Pharmaceutical & Biotechnology Companies |
14.4.3. Diagnostic Laboratories |
14.4.4. CROs and CMOs |
14.4.5. Academic Research Institutes |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.5.1. Brazil |
14.5.2. Mexico |
14.5.3. Argentina |
14.5.4. Rest of LA |
14.6. Latin America Oligonucleotide Synthesis Market - Opportunity Analysis Index, By Product Type, Nucleic Acid Type, Application, and End User, 2016-2027 |
14.7. Latin America Oligonucleotide Synthesis Market Dynamics - Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
15.2.1. Integrated DNA Technologies, Inc. |
15.2.2. GenScript |
15.2.3. Eurofins Scientific SE |
15.2.4. Bioneer Corporation |
15.2.5. Kaneka Corporation (Eurogentec) |
15.2.6. Biolegio B.V. |
15.2.7. Eton Bioscience, Inc. |
15.2.8. IBA GmbH |
15.2.9. Quintara Biosciences |
15.2.10. LGC Biosearch Technologies |
15.2.11. Thermo Fisher Scientific, Inc. |
15.2.12. TriLink BioTechnologies, LLC |
15.2.13. TAG Copenhagen A/S |
15.2.14. PolyGen GmbH |
16. Research Methodology |
17. Key Assumptions and Acronyms |
Key Market Players